You'll hear that pioglitazone (Actos) slows atherosclerosis

You'll hear that pioglitazone (Actos) slows atherosclerosis.

Recent evidence suggests less progression of atherosclerosis in type 2 diabetes patients taking pioglitazone compared to glimepiride (Amaryl).

This doesn't seem to be due to pioglitazone's glucose-lowering might be due to changes in lipids or other factors.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote